|
05 Sep 2025 |
Cipla
|
Consensus Share Price Target
|
1553.10 |
1677.33 |
- |
8.00 |
buy
|
|
|
|
|
26 Jan 2024
|
Cipla
|
Prabhudas Lilladhar
|
1553.10
|
1400.00
|
1369.65
(13.39%)
|
Target met |
Accumulate
|
|
|
|
|
25 Jan 2024
|
Cipla
|
BOB Capital Markets Ltd.
|
1553.10
|
1576.00
|
1369.65
(13.39%)
|
Target met |
Buy
|
|
|
Q3 strong with EBITDA beat of 9% over consensus, though impairment charges of Rs 1.9bn limited PAT outperformance vs consensus
|
|
25 Jan 2024
|
Cipla
|
SMC online
|
1553.10
|
|
1369.65
(13.39%)
|
|
Results Update
|
|
|
|
|
16 Jan 2024
|
Cipla
|
Motilal Oswal
|
1553.10
|
1540.00
|
1302.35
(19.25%)
|
Target met |
Buy
|
|
|
|
|
30 Oct 2023
|
Cipla
|
Axis Direct
|
1553.10
|
1350.00
|
1193.45
(30.14%)
|
Target met |
Buy
|
|
|
We have BUY on the stock
|
|
30 Oct 2023
|
Cipla
|
SMC online
|
1553.10
|
|
1193.45
(30.14%)
|
|
Results Update
|
|
|
|
|
28 Oct 2023
|
Cipla
|
ICICI Securities Limited
|
1553.10
|
1365.00
|
1174.25
(32.26%)
|
Target met |
Buy
|
|
|
Cipla continues to surprise us positively. Q2FY24 growth was led by core markets of India (up 10% YoY), US (~4% QoQ) and South Africa (15% YoY).
|
|
28 Oct 2023
|
Cipla
|
Prabhudas Lilladhar
|
1553.10
|
1350.00
|
1174.25
(32.26%)
|
Target met |
Buy
|
|
|
|
|
28 Oct 2023
|
Cipla
|
BOB Capital Markets Ltd.
|
1553.10
|
1360.00
|
1174.25
(32.26%)
|
Target met |
Buy
|
|
|
Q2 EBITDA/PAT 14%/15% ahead of consensus underpinned by strong growth in US and India businesses
|
|
07 Sep 2023
|
Cipla
|
Geojit BNP Paribas
|
1553.10
|
1420.00
|
1249.30
(24.32%)
|
Target met |
Buy
|
|
|
|